Outcome of Second Line Treatment of Recurrent High-Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study

INTRODUCTION: Currently, there is no standard of treatment for the management of the recurrent high-grade glioma. Re-resection, re-irradiation, and chemotherapy are among main treatment options without any proven efficacy. AIM: To compare the outcome of second line treatment of recurrent high-grade...

Descripción completa

Detalles Bibliográficos
Autores principales: Anvari, Kazem, Shahabadi, Mehri, Welsh, James S., Javadinia, Seyed Alireza, Zarei, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495891/
https://www.ncbi.nlm.nih.gov/pubmed/37247269
http://dx.doi.org/10.31557/APJCP.2023.24.5.1507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495891/
https://www.ncbi.nlm.nih.gov/pubmed/37247269
http://dx.doi.org/10.31557/APJCP.2023.24.5.1507

Ejemplares similares